CSIMarket
 


Becton Dickinson And Company  (BDX)
Other Ticker:  
 
 

BDX's Net Cash Flow Growth by Quarter and Year

Becton Dickinson And's Net Cash Flow results by quarter and year




BDX Net Cash Flow (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter September - 456.00 -1,601.00 -890.00
III Quarter June - -1,043.00 -560.00 -616.00
II Quarter March - 1,324.00 1,273.00 451.00
I Quarter December -247.00 -415.00 -345.00 530.00
FY   -247.00 322.00 -1,233.00 -525.00



BDX Net Cash Flow first quarter 2024 Y/Y Growth Comment
Becton Dickinson And Company in the first quarter 2024 recorded net cash outflow of $ -247.00 millions.

According to the results reported in the first quarter 2024, Becton Dickinson And Company achieved the best Net Cash Flow growth in Medical Equipment & Supplies industry. While Becton Dickinson And Company' s Net Cash Flow no change of % ranks overall at the positon no. 27 in the first quarter 2024.




BDX Net Cash Flow ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter September - - - -
III Quarter June - - - -
II Quarter March - 4.01 % 182.26 % -75.37 %
I Quarter December - - - 2844.44 %
FY   - - - -

Financial Statements
Becton Dickinson And's first quarter 2024 Net Cash Flow $ -247.00 millions BDX's Income Statement
Becton Dickinson And's first quarter 2023 Net Cash Flow $ -415.00 millions Quarterly BDX's Income Statement
New: More BDX's historic Net Cash Flow Growth >>


BDX Net Cash Flow (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter September - - - -
III Quarter June - - - -
II Quarter March - - - -14.91 %
I Quarter December - - - -
FY (Year on Year)   - - - -




Net Cash Flow first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #1
Healthcare Sector #2
Overall #27

Net Cash Flow Y/Y Growth Statistics
High Average Low
10701.71 % 482.22 % -1396.96 %
(Sep 30 2017)   (June 30. 2007)
Net Cash Flow first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #1
Healthcare Sector #2
Overall #27
Net Cash Flow Y/Y Growth Statistics
High Average Low
10701.71 % 482.22 % -1396.96 %
(Sep 30 2017)   (June 30. 2007)

Net Cash Flow by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Becton Dickinson And's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BDX's I. Quarter Q/Q Net Cash Flow Comment
Current results of -247.00 millions by Becton Dickinson And Company look even worse if you take a look at 456.00 millions net cash outflow in the fourth quarter.

Within Medical Equipment & Supplies industry Becton Dickinson And Company achieved highest sequential Net Cash Flow growth. While Becton Dickinson And's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BDX's I. Quarter Q/Q Net Cash Flow Comment
Current results of -247.00 millions by Becton Dickinson And Company appear even more unfavourable considering the net cash outflow 456.00 millions in the fourth quarter.

Within Medical Equipment & Supplies industry Becton Dickinson And Company achieved highest sequential Net Cash Flow growth. While Becton Dickinson And's Net Cash Flow growth quarter on quarter, overall rank is .


Becton Dickinson And's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Net Cash Flow 12 Months Ending $ 490.00 $ 322.00 $ -1,735.00 $ -1,252.00 $ -1,303.00
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) 52.17 % - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 27 # 0 # 0 # 0 # 0




Cumulative Net Cash Flow growth Comment
In the Dec 31 2023 period, Becton Dickinson And had cumulative twelve months Net Cash Flow of $ 490 millions compare to net cash outflow of $ -1,303 millions a year ago.
Singns of revival, although with caution, recording less then standard 52.17 % Net Cash Flow increase, from $322 millions from the twelve months ending in the quarter before.

Becton Dickinson And Company achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
10701.71 %
482.22 %
-1396.96 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 2
S&P 500 # 27
Cumulative Net Cash Flow growth Comment
In the Dec 31 2023 period, Becton Dickinson And had cumulative twelve months Net Cash Flow of $ 490 millions compare to net cash outflow of $ -1,303 millions a year ago.
There is recovery on the way, although with caution, reporting less then usual 52.17 % Net Cash Flow advance, from $322 millions from the twelve months ending in the quarter before Gabriella V. Harris mentioned.

Becton Dickinson And Company achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
10701.71 %
482.22 %
-1396.96 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 2
S&P 500 # 27




Other Net Cash Flow Growth
Medical Equipment & Supplies Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
BDX's Net Cash Flow Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for BDX's Competitors
Net Cash Flow Growth for Becton Dickinson And's Suppliers
Net Cash Flow Growth for BDX's Customers

You may also want to know
BDX's Annual Growth Rates BDX's Profitability Ratios BDX's Asset Turnover Ratio BDX's Dividend Growth
BDX's Roe BDX's Valuation Ratios BDX's Financial Strength Ratios BDX's Dividend Payout Ratio
BDX's Roa BDX's Inventory Turnover Ratio BDX's Growth Rates BDX's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Dec 31 2023
Astrazeneca Plc-5.29%$ -5.287 millions
Lipocine Inc -6.98%$ -6.984 millions
Caredx Inc -14.62%$ -14.617 millions
Sophia Genetics Sa-16.41%$ -16.406 millions
Xencor Inc-17.78%$ -17.780 millions
Kronos Bio Inc -20.78%$ -20.784 millions
Earth Science Tech Inc -21.38%$ -21.381 millions
Hookipa Pharma inc -22.19%$ -22.193 millions
Anaptysbio Inc -24.22%$ -24.222 millions
Koru Medical Systems Inc-26.57%$ -26.570 millions
Abbott Laboratories-35.07%$ -35.069 millions
Lantheus Holdings Inc -37.16%$ -37.161 millions
Alcon inc -37.78%$ -37.778 millions
Inflarx N v -38.04%$ -38.037 millions
Novartis Ag-39.41%$ -39.413 millions
Argenx se-40.00%$ -40.005 millions
Gh Research Plc-40.04%$ -40.040 millions
Bright Minds Biosciences Inc -41.15%$ -41.154 millions
Enzon Pharmaceuticals inc -42.33%$ -42.332 millions
Myriad Genetics Inc -44.65%$ -44.653 millions
Elutia inc -46.46%$ -46.456 millions
Gilead Sciences Inc -46.70%$ -46.704 millions
Koninklijke Philips Nv-49.11%$ -49.110 millions
Avidity Biosciences Inc -49.45%$ -49.449 millions
Proqr Therapeutics N v -49.46%$ -49.460 millions
Protalix Biotherapeutics inc -49.52%$ -49.523 millions
Xeris Biopharma Holdings Inc -49.99%$ -49.994 millions
Altair International Corp -52.34%$ -52.344 millions
Macrogenics Inc -55.57%$ -55.574 millions
Atricure Inc -59.98%$ -59.983 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com